Frequently Asked Questions

What is the involvement of Boeringher Ingleheim Canada?

Boehringer Ingelheim Canada has provided funding for this program through their Healthcare Solutions and Partnerships team.

Who is ICI Medical Communications? What is their role in this project?

ICI Medical Communications had been providing access to diabetes education since 2014 through webinars and on demand learning. Our role is to manage the development and dissemination of this program and to support the winners in developing materials and disseminating their projects. ICI is available to provide advice, feedback and direct services in the selection, development and distribution of knowledge sharing activities.

How can funds be used?

Funds will ideally be used to develop promotional materials or educational events, such as webinars, to share your ideas with as many people working in diabetes as we can. Funds can be used to enhance existing practices. However, funds cannot be used to support travel to events, as per the  Innovative Medicines Code of Conduct

How will funds be distributed?

Funds will be distributed by ICI Medical Communications to the selected winners. Winners will be contacted by ICI Medical Communications to discuss funding plans to ensure compliance with all appropriate Canadian regulations. 

The Knowledge to Action Challenge is presented by ICI Medical Communications in collaboration with Boehringer Ingelheim. This project has been fully endorsed by our partner organizations Société des Sciences Vasculaires de Quebec, and CPD Network.